Rapidly screen for harmful pathogens, such as viruses (SARS-CoV-2), bacteria, fungi, and parasites in your facilities.
The Coronavirus pandemic has increased the need for governments, companies, universities, and other institutions to have fast and accurate information about the safety of their facilities. This need will become even more pressing as people begin to re-enter the workforce. Research shows that SARS-CoV-2 can be infectious for hours in the air after aerosolized and may persist on surfaces such as stainless steel or plastic for up to a week. Employers and employees will want to know that their workplaces are free of pathogens, such as SARS-CoV-2, the virus that causes COVID-19.
In order to aid in that goal, Igenbio, Inc. is launching a new service, named RAPID™️.
RAPID will accurately & rapidly detect disease causing pathogens such as:
Viruses (SARS-CoV2, Ebola, Influenza, Chikungunya, and others)
Bacteria (Listeria, Escherichia Coli, Mycobacterium tuberoculosis, Streptococcus pneumoniae, Staphylococcus aureus, MRSA, and others).
Fungi (Candida auris, Candida albicans, Cryptococcus neoformans, and others)
Parasites (Plasmodium spp., Leishmania spp., and others).
Our technology utilizing long-read sequencing and cutting-edge bioinformatics enables us to more accurately detect pathogens where rtPCR/qPCR techniques may fail.